Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Lane

Showing results (71-80 of 145) with videos related to

Pageof 15
Sort By:
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.
Journal of Cellular Biochemistry|August 26, 2003
Regulation of nitric oxide and bcl-2 expression by shear stress in human osteoarthritic chondrocytes in vitroMel S Lee, Michael C D Trindade, Takashi Ikenoue, et al.
Molecular Pharmacology|June 27, 2013
Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptorPeter Keov, Celine Valant, Shane M Devine, et al.
Molecular Pharmacology|December 23, 2011
A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptorJ Robert Lane, Carmen Klein Herenbrink, Gerard J P van Westen, et al.
ACS Chemical Neuroscience|February 12, 2024
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein SignalingMeng-Hua M Tsai, Li Chen, Michael H Baumann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 18, 2008
Antibodies that identify only the active conformation of G(i) family G protein alpha subunitsJ Robert Lane, David Henderson, Ben Powney, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2010
Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primatesMelissa Suter, Philip Bocock, Lori Showalter, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
The <i>in vitro</i> functional profiles of fentanyl and nitazene analogs at the μ-opioid receptor - high efficacy is dangerous regardless of signaling biasMeng-Hua M Tsai, Li Chen, Michael H Baumann, et al.
The Journal of Pediatrics|December 3, 2014
Patching the pipeline: creation and retention of the next generation of physician-scientists for child health researchDavid N Cornfield, Robert Lane, Norman D Rosenblum, et al.
Scientific Reports|April 16, 2021
New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D<sub>2</sub> receptor regulation and signalingAnika Mann, Alastair C Keen, Hanka Mark, et al.
Pageof 15

Showing results (71-80 of 145) with videos related to

Sort By:
Pageof 15
Journal of Medicinal Chemistry|June 9, 2015
Structure-activity study of N-((trans)-4-(2-(7-cyano-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)cyclohexyl)-1H-indole-2-carboxamide (SB269652), a bitopic ligand that acts as a negative allosteric modulator of the dopamine D2 receptorJeremy Shonberg, Christopher Draper-Joyce, Shailesh N Mistry, et al.
Journal of Cellular Biochemistry|August 26, 2003
Regulation of nitric oxide and bcl-2 expression by shear stress in human osteoarthritic chondrocytes in vitroMel S Lee, Michael C D Trindade, Takashi Ikenoue, et al.
Molecular Pharmacology|June 27, 2013
Reverse engineering of the selective agonist TBPB unveils both orthosteric and allosteric modes of action at the M₁ muscarinic acetylcholine receptorPeter Keov, Celine Valant, Shane M Devine, et al.
Molecular Pharmacology|December 23, 2011
A novel nonribose agonist, LUF5834, engages residues that are distinct from those of adenosine-like ligands to activate the adenosine A(2a) receptorJ Robert Lane, Carmen Klein Herenbrink, Gerard J P van Westen, et al.
ACS Chemical Neuroscience|February 12, 2024
In Vitro Functional Profiling of Fentanyl and Nitazene Analogs at the μ-Opioid Receptor Reveals High Efficacy for Gi Protein SignalingMeng-Hua M Tsai, Li Chen, Michael H Baumann, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 18, 2008
Antibodies that identify only the active conformation of G(i) family G protein alpha subunitsJ Robert Lane, David Henderson, Ben Powney, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 25, 2010
Epigenomics: maternal high-fat diet exposure in utero disrupts peripheral circadian gene expression in nonhuman primatesMelissa Suter, Philip Bocock, Lori Showalter, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2023
The <i>in vitro</i> functional profiles of fentanyl and nitazene analogs at the μ-opioid receptor - high efficacy is dangerous regardless of signaling biasMeng-Hua M Tsai, Li Chen, Michael H Baumann, et al.
The Journal of Pediatrics|December 3, 2014
Patching the pipeline: creation and retention of the next generation of physician-scientists for child health researchDavid N Cornfield, Robert Lane, Norman D Rosenblum, et al.
Scientific Reports|April 16, 2021
New phosphosite-specific antibodies to unravel the role of GRK phosphorylation in dopamine D<sub>2</sub> receptor regulation and signalingAnika Mann, Alastair C Keen, Hanka Mark, et al.
Pageof 15